Genomic Imprinting and Human Reproduction by Lebedev, I.N.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 5
Genomic Imprinting
and Human Reproduction
I.N. Lebedev
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/57241
1. Introduction
The high frequency of reproductive losses is specific to the human race. The chances of
conceiving and giving birth to a healthy child for women between 20 and 30 years old are
estimated to be as low as 21-28% per cycle [1]. About 60% of zygotes are eliminated during the
pre-implantation or early post-implantation developmental stages and 15-20% of clinically
recognized pregnancies are lost during the first trimester [2]. Approximately 50-60% of
spontaneously aborted embryos have chromosomal abnormalities which are not compatible
with prenatal development [3]. At the same time, the death of another considerable number
of embryos with normal karyotypes cannot be explained by existing cytogenetic theories.
Considering ontogenesis as a result of the unrolling of the strict developmental program, the
epigenetic basis of this process may be of outstanding significance.
According to the classical definition, coined by Conrad Waddington in 1942, epigenetics is a
branch of biology which studies “causal mechanisms” by which “the genes of the genotype
bring about phenotypic effects” [4]. In its beginning, epigenetics was a synonym for develop‐
mental genetics. However, in contrast to classical genetic theories, the subject of epigenetics
has a wider diversity of phenomena, which may be unrelated to changes in gene nucleotide
sequences [5]. A strong surge of interest in studying the epigenetic basis of human hereditary
pathology has been noted over the last several years [6, 7]. New classes of epigenetic diseases,
namely chromatin diseases [8] and imprinting disorders [9] have been identified. However,
little is known about the features and nature of epigenetic abnormalities, i.e., epimutations,
[10] during human prenatal development. In this chapter information on the impact of genomic
imprinting abnormalities on embryo development is summarized and discussed.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Genomic imprinting and its role in embryogenesis
Genomic imprinting is an epigenetic phenomenon, which is related to differential parent-of-
origin gene expression. The term “imprinting” was taken from physiology. It was Konrad
Lorenz, an Austrian zoologist, ethologist and ornithologist, who, when working with geese,
rediscovered the principle of imprinting (originally described by Douglas Spalding in the
19th century) in the behaviour of nidifugous birds when a young bird acquired several of its
behavioural characteristics from one parent.
The term “chromosomal imprinting” was coined in 1960 by Helen Crouse, one of only three
PhD students trained by Nobel Laureate Barbara McClintock. Crouse described the selective
elimination of paternal chromosomes in the male meiosis in Sciara fly [11]. In the first meiotic
division of spermatogenesis, a monopolar spindle forms upon which all the maternally derived
homologues move to a single pole and all the paternally derived homologues move away from
the single pole and are completely eliminated from the cell as a nucleoplasmic bud. Crouse
wrote, “the ‘imprint’ a chromosome bears is unrelated to the genetic construction of the
chromosome and is determined only by the sex of the germ line through which the chromo‐
some has been inherited” (cited in [12]). At the time that Crouse first used the term, chromo‐
some imprinting was known to occur in Sciara spermatogenesis. This mechanism of selected
chromosome segregation remains enigmatic, although much headway has been made in
mammalian systems [12].
The first evidence of the parental genome’s memory in mammals came from experiments
conducted by the Surani, McGrath and Solter groups with pronuclei transplantation in mouse
zygotes in 1984 [13, 14]. These studies were aimed at answering the question about the absence
of parthenogenesis in mammalian reproduction. It was discovered that diploid androgenic
mouse embryos derived from zygotes, which contained two paternal pronuclei and none of
the maternal pronuclei, demonstrated an extensive proliferation of extraembryonic tissues but
poor development of the embryo per se, which usually did not reach a 4-6 somite stage. In
contrast, gynogenic zygotes with two maternal pronuclei and an absence of the paternal
genome resulted in embryos which developed until the stage of early somites, but then died
due to the poor development of supportive extraembryonic tissues. These pioneers’ studies
established that diploidy alone is not sufficient for embryonic development, but that a balance
of maternal and paternal genomes is strongly required for normal embryogenesis. Moreover,
the impact of parental genomes on embryo development is different. It seems that the maternal
genome is responsible for the development of the embryo body to a greater extent, whereas
the paternal one is involved in the support of extraembryonic tissue differentiation.
It is interesting to note that a similar effect of the increasing number of paternal genomes in
the zygote is also observed in humans due to an abnormality of fertilization [15]. Fertilization
of a diploid oocyte by normal haploid sperm or double fertilization of a normal oocyte by two
haploid sperms leads to triploidy in the zygote. In this case, the partial hydatidiform mole
(PHM) arises. PHM is characterized by the cystic degeneration of chorionic villi and the
presence of a visible embryo in the foetal sac. In the case of the extrusion of the maternal
pronucleus from such a triploid zygote, a diploid karyotype is restored through the postzygotic
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triploid diploidization mechanism [16], but both haploid genomes are paternal in their nature.
This bipaternal karyotype is not compatible with the development of an embryo body, but
leads to a hyper proliferation of trophoblasts cells and a complete hydatidiform mole (CHM)
with an increased risk of chorioepithelioma. The observed effect may be explained by the
double increase in the dose of imprinted genes expressed from paternal chromosomes, which
promotes proliferative and invasive activity of the trophoblasts cells as well as an absence of
activity of the maternal imprinted genes, which, in turn, must suppress trophoblast prolifer‐
ation.
The parental differences in imprinted genes expression are epigenetic in their nature. They are
established during gamete differentiation by sex-dependent epigenetic chromatin modifica‐
tions, mainly by the differential DNA methylation of promoter regions of imprinted genes or
regulatory imprinted centres, which are further stably inherited in the somatic cells of the
progeny. These regular and consecutive alterations of chromatin organization are referred to
as epigenetic genome reprogramming [17, 18] (Figure 1). This starts in the primordial germ
cells when they enter the gonads. Both imprinted and non-imprinted loci become demethy‐
lated. This total erasure of epigenetic information is required for the totipontency of future
germ cells, imprinting switching and for the prevention of the inheritance of epigenetic defects.
The demethylated chromatin’s state remains until the duration of the mitotic arrest in male
germ cells and the meiotic arrest in female ones. When mitotic divisions of spermogonia are
resumed, de novo DNA methylation begins, which terminates completely by the time of
pachytene of meiosis I. In oocytes, de novo DNA methylation starts only at their maturation
and ends by metaphase II. In this period, sex-specific methylation of imprinted genes is
established. In one imprinting genes, DNA methylation occurs exclusively in oogenesis,
whereas in others it occurs during spermatogenesis [19].
The second wave of epigenetic genome reprogramming, which involves somatic cells, begins
immediately after fertilization. The paternal chromosomes became decondensed, protamines
in the chromatin are replaced by histones and fast demethylation of paternal genome is
triggered. The maternal genome undergoes slow passive demethylation. It is believed that
demethylation of parental genomes is required to induce pluripotency in embryonic stem cells.
Later, during implantation, de novo DNA methylation is launched again, which results in
specific methylation patterns of particular genomic regions in different cells and tissues. This
process, in fact, provides one of the most important mechanisms for committing and regulating
tissue specific gene expression during ontogeny. It is significant that imprinted genes avoid
this reprogramming wave in somatic cells, preserving their differential methylation pattern
inherited from the parents. Genomic imprinting is also regulated through other epigenetic
mechanisms, such as histone modifications, antisense transcripts and small non-coding RNA,
which have been discussed in detail in some comprehensive reviews [19, 20].
At present, (August 2013), it is reported that there are about 90 imprinted genes in a human
genome [21]. Most of them are involved in the regulation of intrauterine foetal development
through the control of cell proliferation and the differentiation of placental tissues, regulation
of metabolism of some hormones and growth factors [22]. The evolutionary reverse to the
haploid expression of a subset of genes in mammalian and flowering plants genomes was a
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great surprise. Several hypotheses were introduced to explain this intriguing fact, but the “sex
conflict” was one the most popular among them [23]. According to this hypothesis, maternal
imprinted genes in mammals are responsible for the suppression of foetal growth in order to
save maternal resources for subsequent pregnancies. In contrast, paternal imprinted genes are
involved in the promotion of foetal growth that provides higher chances of survival for many
offspring.
Testing this hypothesis in mouse models, the direct evidence for the significant role of genomic
imprinting in mammalian embryo development was obtained. The generation of uniparental
disomies (UPD) in progeny of translocation carrier’s mice gives nonviable embryos [24]. This
fact leads to the idea of searching for UPD in human spontaneous abortions in order to estimate
the impact of genomic imprinting abnormalities on prenatal death.
3. UPD in spontaneous abortions
To date, eight studies have been performed to find UPD in spontaneous abortions [25-32]
(Table 1). However, the obtained results were modest. Only seven cases of UPD (2.3%) among
a total of 305 spontaneous abortions were found and most of them involved chromosomes
which did not contain known imprinted genes. Only in three cases segmental UPD (16p/16q
(mat), 14q (pat) and 7q (mat)) embryo death can be connected with a disturbance of the dose
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Figure 1. Dynamics of epigenetic genome reprogramming
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of imprinted genes localized on these chromosomal regions. Moreover, spontaneous abortions
without previous cytogenetic analysis were included in some studies that could have led to
overestimation the obtained rate. As a result, the frequency of UPD for chromosomes, which
contain known imprinted genes in spontaneous abortions were estimated to be 1% (3/305) or
1.14 per 1,000 occasions of chromosome inheritance from parents to progeny. The latter figure
was obtained from the investigation of 6,156 cases of chromosome inheritance by DNA
microsatellite analyses and seven cases of UPD were found in the eight cited studies. This
figure does not significantly differ from the expected frequency (1.65:1,000), predicted from
data about frequencies of chromosome segregation errors in gametogenesis and early em‐
bryogenesis, which can lead to uniparental inheritance in humans [33].
Thus, it seems that UPD is a selectively neutral phenomenon in human reproduction. More‐
over, UPD for some chromosomes (6, 7, 11, 14 and 15) are compatible with postnatal life leading
Samples
Number of spontaneous
abortions
UPD cases References
Anembryonic pregnancies without
cytogenetic analysis
23
UPD(21)mat,
UPD(21)mat in combination
with trisomies 7 and 9
[25]
Spontaneous abortions:
18 0 [26]- first trimester, without cytogenetic
analysis
- with normal karyotype 35 0 [27]
- 6-22 weeks, with normal karyotype 71
UPD(9)mat
UPD(21)mat
[28]
- with normal karyotype 24
Maternal segmental heterosomy 16pter-
D16S3107
and isodisomy
D16S3018-qter
[29]
- with normal karyotype 81
Segmental UPD(14q)pat,
UPD(7q)mat
[30]
Missed abortions and anembryonic
pregnancies:
- with 46,ХХ karyotype (analysis of X-
chromosome inheritance only)
52* 0 [31]*
- with normal karyotype 87* 0 [32]*
Total: 305 7 (2,3%)
Note: * - samples partially overlap.
Table 1. Results of UPD studies in spontaneous abortions
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to a formation of specific genomic imprinting disorders: transient neonatal diabetes mellitus
(TNDM), Silver-Russell syndrome (SRS), Beckwith-Wiedemann syndrome (BWS), Wang and
Temple syndromes, Prader-Willi syndrome (PWS) and Angelman syndrome (AS), respective‐
ly [34]. It became clear that UPD is a rare cytogenetic phenomenon, which cannot explain the
mechanisms of imprinted genes disturbances in human pregnancy loss. The only evidence for
the pathogenetic role of genomic imprinting abnormalities in human reproduction remains
from studies on a hydatidiform mole which originated from the doubling of paternal genome
in conception [15]. However, this conclusion does not offer an answer on the possible mech‐
anisms of imprinting disturbances associated with early pregnancy loss.
4. Epimutations of imprinted genes in spontaneous abortions
Taking into account the epigenetic nature of genomic imprinting, we proposed a hypothesis
that expected the deleterious effect of abnormal imprinted genes expression to be visible at the
epigenetic rather than cytogenetic level [35]. Indeed, UPD formation requires a combination
of several subsequent errors in chromosomal segregation during parental meiosis, fertilization
and embryo development. For example, the most frequent mechanism of UPD formation is
trisomy rescue. It arises from chromosomal nondisjunction in meiosis, trisomy formation in
the zygote after fertilization and the loss of additional chromosome in some somatic cells
during subsequent mitotic divisions. In a third of the cases of such correction, the situation of
inheritance of both homologues from one parent may be observed. If involved chromosome
contains an imprinted gene, then the double increase or complete loss of expression of
imprinted genes may be detected and it is dependent on the parental origin of expressed allele.
Epimutation 
(hypomethylation of 
imprinted gene on 
maternal chromosome) 
Normal 
cells 
UPD pat 
CH3 
CH3 CH3 CH3 CH3 
Figure 2. Effects of UPD and epimutations on expression of imprinted genes.
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On the other hand, the change of the imprinted gene dose may be achieved by epimutations,
i.e., abnormal methylation of the expressed allele or demethylation of the silenced allele. From
a functional point of view, epimutations and UPD influences on imprinted genes expression
should be similar (Figure 2). It is important that epimutation on a single allele is enough to
achieve the imprinted gene dysfunction in a dominant manner.
Before the testing of the hypothesis about the influence of methylation defects in imprinted
genes on the aetiology of early pregnancy loss, a classification of epimutations was introduced
[36]. They were divided into the following several groups depending on their germinal or
somatic origin, hyper- or hypomethylation of active or silenced alleles, and affected parental
chromosomes (Table 2):
1. Types of epimutations of imprinted genes by the loci involved:
1.1. Epimutations causing a global disturbance of genomic imprinting at the genome level.
1.2. Epimutations at the imprinting centres causing a disturbance of imprinting of neighbouring genes.
1.3. Epimutations at the imprinted genes.
2. Types of epimutations of imprinted genes by their origin:
2.1. Germinal epimutations
2.1.1. Errors of genomic imprinting erasure in primordial germ cells with retention of methyl
groups (Critical Period 1, CP #1, on Figure 1). These errors may lead to transgenerational inheritance
of epigenetic defects.
2.1.2. Errors of imprinting establishment during gametogenesis (CP #2 on Figure 1)
2.1.2.1. Absence of methylation of imprinted genes alleles that normally should be
methylated in sperm or oocytes.
2.1.2.2. Aberrant methylation of imprinted genes alleles that normally should be
unmethylated in sperm or oocytes.
2.2. Somatic epimutations
2.2.1. Abnormal hypomethylation of inactive parental alleles of imprinted genes during epigenetic
genome reprogramming (CP #3 on Figure 1).
2.2.2. Abnormal methylation of expressed parental alleles of imprinted genes during de novo DNA
methylation upon epigenetic genome reprogramming (CP #4 on Figure 1).
2.2.3. Spontaneous hypomethylation of inactive parental alleles of imprinted genes in somatic cells
after epigenetic genome reprogramming (CP #5 on Figure 1).
2.2.4. Spontaneous hypermethylation of expressed parental alleles of imprinted genes in somatic
cells after epigenetic genome reprogramming (CP #5 on Figure 1).
3. Types of epimutations of imprinted genes by their functional consequences and affected parental alleles:
3.1. Hypomethylation of the inactive maternal allele of the imprinted gene.
3.2. Hypomethylation of the inactive paternal allele of the imprinted gene.
3.3. Hypermethylation of the expressed maternal allele of the imprinted gene.
3.4. Hypermethylation of the expressed paternal allele of the imprinted gene.
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Type of epimutations
Abnormal hypomethylation of Abnormal hypermethylation of
maternal allele paternal allele maternal allele paternal allele
Ge
rm
ina
l e
pim
uta
tio
ns
Errors of genomic
imprinting erasure with
retention of methyl groups
(CP #1)
Not applicable Not applicable
IGF2/H19
(BWS)
SNURF-SNRPN
(PWS);
PEG1/MEST (SRS)
Absence of imprinted genes
alleles methylation (CP #2)
BiCHM;
IGF2/H19
(SRS)
Not applicable Not applicable
SNURF-SNRPN (AS);
KCNQ1OT1
(BWS, TNDM);
PLAGL1 (TNDM, BWS)
Aberrant hypermethylation
of imprinted genes alleles
(CP #2)
Not applicable Not applicable
IGF2/H19
(BWS)
SNURF-SNRPN
(PWS); PEG1/MEST
(SRS)
So
ma
tic
 ep
im
uta
tio
ns
Abnormal hypomethylation
of inactive parental alleles
of imprinted genes during
epigenetic genome
reprogramming (CP #3)
SNURF-SNRPN
(mosaic forms of AS).
MHS;
mosaic forms of TNDM
Partial hypomethylation
of IGF2/H19 (SRS)
Not applicable Not applicable
Abnormal
hypermethylation of
expressed parental alleles of
imprinted genes during
epigenetic genome
reprogramming (CP #4)
Not applicable Not applicable
IGF2/H19
(BWS)
SNURF-SNRPN
(PWS)
Stochastic epimutations
(hypo- and
hypermethylation) in
somatic cells after
epigenetic genome
reprogramming (CP #5)
KCNQ1OT1 (oesophagus
carcinoma, liver cancer);
P73 (renal carcinoma;
lung cancer)
IGF2/H19
(Wilm’s tumour);
SNURF-SNRPN
(mosaic forms of PWS);
P73 (acute leukaemia,
Burkitt’s lymphoma);
PEG3 (cervical and
endometrial
carcinomas);PEG3 (choriocarcinoma)
DLK1/GTL2 (renal
carcinoma)
PLAGL1 (ovarian cancer)
Table 2. Types of epimutations of imprinted genes in human (according to [36] with modifications)
The first evidence of epimutations in imprinted genes in reproductive losses came from studies
of biparental complete hydatidiform mole (BiCHM, MIM #231090). This pathology, as opposed
to classical androgenic complete mole, arose in the case of normal biparental karyotype [37]
(Figure 3). It was shown that imprinted genes, which are methylated on maternal chromo‐
somes in normal embryos, became hypomethylated in the case of BiCHM both on the paternal
and maternal homologues [15]. Functionally, this epigenetic status is the same as an androgenic
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complete mole. Subsequent studies revealed that BiCHM arose due to germinal epimutations,
namely the absence of de novo methylation of imprinted genes in oogenesis (type # 2.1.2.1
according to classification) [38]. However, these findings do not offer an answer about the
prevalence of imprinting defects in human reproductive losses. The convenient model system
for studies became spontaneous abortions.
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Figure 3. Cytogenetic and epigenetic mechanisms of hydatidiform mole formation.
The first study devoted to the analysis of methylation status of SNRPN imprinted gene was
published by our group in 2006 [39]. However, it was shown that all investigated spontaneous
abortions, as well as the control sample of induced (therapeutic) abortions, had normal
differential methylation of parental alleles of this imprinted gene.
Our further studies on imprinted genes PLAGL1 (ZAC), CDKN1C and regulatory imprinting
centres IGF2/H19 and KCNQ1OT1 (LIT1) in spontaneous abortions revealed that 9.5% and
10.3% of embryos with normal karyotype had hypomethylation of KCNQ1OT1 and PLAGL1,
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respectively, on maternal chromosomes [35, 40]. It is interesting that in two embryos from the
investigated group (2.3%) epimutations were detected in both genes. In both families, the
women had not had a successfully delivered pregnancy. In one family, the woman had had
four spontaneous abortions, in the other, the woman had had two spontaneous abortions and
a stillbirth. It was shown that the frequency of recurrent pregnancy loss (i.e., the loss of three
or more consecutive pregnancies) was significantly higher in woman who had had a loss of
methylation in PLAGL1 in spontaneous abortions tissues, in comparison with woman without
epimutations in the aborted embryo (33% and 8%, respectively, p < 0.05). A similar tendency
was observed for KCNQ1OT1 epimutations, but it does not reach a statistically significant
difference.
It was remarkable also that all detected epimutations were confined to one placental tissue
(cytotrophoblast or extraembryonic mesoderm) only indicating their somatic origin in post-
implantation stages of development after the divergence of embryonic and extraembryonic
cell lineages. This observation has an important value for the discussion on the increase of
genomic imprinting disorders in children born after the application of assisted reproductive
technologies (ART) [20, 41-44]. Indeed, several cases of children with BWS, SRS and AS born
after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) have been reported.
However, it is more significant that all patients with confirmed molecular diagnosis had
hypomethylation of imprinted genes on maternal chromosomes as a cause of disorder among
all the other known possible mechanisms which can alter imprinted genes expression – UPD,
chromosomal microdeletions or microduplications, point mutations in imprinted genes or
regulatory imprinted centres. This fact is supported by results of in vitro studies in model
organisms [45]. This often leads to a hasty one-sided conclusion that manipulations with
gametes and embryos in an artificial medium cannot support correct recording and mainte‐
nance of genomic imprinting and they are responsible for an increase of imprinting defects in
children after ART. Our, and other, recently published data from spontaneous abortions
studies [46] indicates that the same epimutations with relatively high frequency can be
observed in embryos from natural cycles also and not only from IVF or ICSI pregnancies. This
means that epimutations of imprinted genes arising during human embryo development, and
infertile pairs or couples with the history of recurrent pregnancy losses (typical patients of
ART clinics), may have increasing chances to produce progeny with epimutations after
overcoming the natural reproductive barriers by IVF or ICSI. This conclusion implies that the
nature of epimutations involves the interaction of hereditary and environmental factors.
Evidence for epimutations of imprinted genes in spontaneous abortions was also noted in other
subsequent studies (See tables 3 and 4). For example, multiple hypermethylation of imprinted
genes was detected in 4% (2 out of 55) of spontaneous abortions and 18% (10 out of 57) of
stillbirths [47]. In this study, H19, KCNQ1OT1, PEG3 and SNRPN genes with paternal expres‐
sion and MEG3 and NESP55 with maternal expression were investigated. In other studies, the
expression level of several imprinted genes was compared between placental tissues from
normal pregnancies and pregnancies complicated by intrauterine growth retardation (IUGR)
[48]. It was found that PHLDA2, ILK2, NNAT, CCDC86 and PEG10 genes had increased
expression in IUGR pregnancies, whereas the expression level of PLAGL1, DHCR24,
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ZNF331, and CDKAL1 was decreased. In this study, hypomethylation of DLK1, H19, and
SNRPN was demonstrated also in the placental tissues of foetuses with IUGR. In another study,
expression levels of four imprinted genes (IGF2, PEG10, PHLDA2, and CDKN1C) were
investigated in embryonic and placental tissues of 38 spontaneous abortions [49]. The in‐
creased expression of PHLDA2 was found both in the embryonic and placental tissues in the
first trimester. During the second trimester, elevated expression levels of all four genes were
observed in both tissues, however, for the PHLDA2 gene it was specific to the embryonic tissues
only. A decreased expression of PEG3 was detected in embryonic tissues during the third
trimester.
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SA 55 МТ 3.6%(2) - - - 2↑ 1↑ - 1↑ - - - - - - - [47]
SB 57 МТ 17.5%(10) - - - 6↑ 2↑ - 9↑ - - - - - - - [47]
SA 87 CC 2.3%(2) 2↓ - - - 2↓ - 0 - - - - - - - [40]
SA 13 CC 100%(13) 1↓ 3↓ 0 0 0 2↑ 2↑ 4↓ 5↓ 3↓ 2↓ 1↑ 0 3↑ [50]
SA 13 EM 100%(13) 2↓ 9↓ 9↓ 0 0 7↑ 10↑ 10↓ 3↓ 5↓ 6↓ 5↑ 0 7↑ [50]
SA 165 CC 3.6%(6) - - - - 6↑ - 7↑ - - - - - - - [46]
SA 29 CC 10.3%(3) - - - 1↓, 2↑ 2↑ - 1↑ - - - - - 1↑ - [51]
To
tal 406 12.1%(49) 5.0
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(5/
10
0)
46
.2%
 (1
2/
26
)
34
.6%
 (9
/2
6)
7.1
% 
(11
/1
54
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3.2
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(13
/4
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34
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/2
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(30
/4
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.8%
 (1
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26
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 (8
/2
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30
.8%
 (8
/2
6)
30
.8%
 (8
/2
6)
23
.1%
 (6
/2
6)
1.8
% 
(1/
55
)
38
.5%
 (1
0/
26
)
↓ - 16.0% (65/406); ↑ - 18.7% (76/406)
Notes for tables 3 and 4: SA – spontaneous abortion; SB – stillbirth; МТ – muscular tissues of embryo; CC – chorion
cytotrophoblast; EM – extraembryonic mesoderm; MLMD – multilocus methylation defects (number of embryos with
MLMD is indicated in parentheses); ↓ – hypomethylation; ↑ – hypermethylation.
Table 3. Frequency of epimutations in paternally expressed imprinted genes in spontaneous abortions
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Pathology Samplesize Tissue
MLMD
frequenc
y
GRB10
(7q21)
CPA4
(7q32)
PHLDA2
(11p15)
ZNF215
(11p15)
H19
(11p15)
MEG3
(14q32)
NESP55
(20q13.3) Ref.
SA 55 МТ 3.6% (2) - - - - 0 1↑ 0 [47]
SB 57 МТ 17.5%(10) - - - - 4↑ 8↑ 6↑ [47]
SA 87 CC 2.3% (2) - - - - 0 0 - [40]
SA 13 EM 100% (13) 1↓ 8↓ 2↓ 8↓ 1↑ 0 0 [50]
SA 13 CC 100% (13) 5↓ 5↓ 9↓ 4↓ 6↑ 0 0 [50]
SA 165 CC 3.6% (6) - - - - 4↑ - - [46]
SA 29 CC 10.3% (3) - - - - 0 0 0 [51]
Total 406 12.1%(49)
23.1%
(6/26)
50.0%
(13/26)
42.3%
(11/26)
46.2%
(12/26)
3.7%
(15/406)
3.7%
(9/241)
3.9%
(6/154)
↓ - 10.3% (42/406); ↑ - 7.4% (30/406)
Table 4. Frequency of epimutations in maternally expressed imprinted genes in spontaneous abortions
It is important to note that all the above mentioned studies were performed by the “candidate
gene” approach, i.e., only several interesting genes were tested based on their supposed
functions in embryogenesis. A new era in this area of research began with the application of
array technologies. They provide comprehensive and unbiased analysis of the human
imprintome. Results of the first studies revealed a new, intriguing phenomenon of multilocus
methylation defects (MLMD) on imprinted genes. This effect is presented by multiple epimu‐
tations (hypo- and/or hypermethylation) affecting several imprinted genes simultaneously in
the genome in different combinations. In fact, the first example of MLMD is a BiCHM, which
results from errors of imprinting establishment on maternal chromosomes during epigenetic
genome reprogramming in oocytes leading to the hypomethylation of maternal alleles of
different imprinted genes [38]. MLMD were detected in human reproductive losses [50] as
well as in patients with genomic imprinting disorders [52]. Importantly, in one recent study
15 (8%) probands among 194 patients with clinical features of an imprinting disorder but no
molecular diagnosis had methylation anomalies, including missed and unexpected molecular
diagnosis [53].
Evidence of MLMD in 13 first trimester spontaneous abortions were obtained in our study by
DNA methylation array the GoldenGate Methylation Cancer Panel I (Illumina) analysis of 51
imprinted genes [50]. Multiple methylation defects affecting from four to 12 genes in each
embryo were found. Epimutations were presented by the hypomethylation of paternal alleles
of GRB10, CPA4, PHLDA2, ZNF215 genes, and maternal alleles of PEG10, PLAGL1, WT1,
HTR2A, DLK1, GABRB3, KCNQ1 genes. Hypermethylation was observed on paternal allele of
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H19 and on maternal alleles of INS, TRPM5, PWCR1, GABRA5 genes. The majority of epimu‐
tations (78%) were confined to single placental tissue (extraembryonic mesoderm or cytotro‐
phoblast), indicating postzygotic errors in imprinting maintenance in somatic cells.
Summarizing the published data, it is possible to note that MLMD were observed in 49 of 406
investigated spontaneous abortions (12%) (See tables 3 and 4). It is evident that this value, of
a significant magnitude greater than UPD frequency in miscarriages, indicates an appreciable
effect of epigenetic defects on imprinted genes in pregnancy losses. The incidence of epimu‐
tations for different genes varied from 1.8% (MEST) to 53.8% (WT1). For genes expressed from
maternal chromosomes, the frequency of epimutations was 17.7%, with 10.3 % of these
presented by the hypomethylation of respective inactive paternal alleles and 7.4% by the
hypermethylation of active maternal alleles. For genes expressed from the paternal allele, the
total frequency of epimutations was twice as frequent (34.7%). These epimutations were
presented by the hypomethylation of respective inactive maternal alleles (16%) and the
hypermethylation of expressed paternal alleles (18.7%).
The results of the studies suggest possible mechanisms of the selective influence of epimuta‐
tions of imprinted genes on early embryo development. As it was mentioned early, the “sex
conflict” hypothesis is the most popular in explaining the imprinted mode of gene expression.
From its point of view, the expected suppressive effect of epimutations should emerge from
the hypomethylation of paternal alleles, which leads to a loss of imprinting and the biallelic
expression of maternal genes responsible for foetal growth suppression, as well as from
hypermethylation of paternal alleles, which leads to the absence of products responsible for
foetal growth stimulation. The total incidence of such types of epimutations in spontaneous
abortions is 29% (10.3 + 18.7). At the same time, the total incidence of epimutations, which can
lead to the promotion of foetal growth (hypo- and hypermethylation of maternal alleles), was
23.4% (16 + 17.4). The differences between frequencies of “suppressive” and “promotion”
epimutations were not statistically significant (p = 0.07). However, this is a relative estimation
for several reasons, including complete acceptance of the “sex conflict” hypothesis for each
imprinted gene (maternal genes are suppressors, paternal genes are activators) and the idea
that there is a strong reverse correlation between gene methylation and its expression. To
obtain more precise and weighted estimations, further studies of imprinted gene functions and
molecular mechanisms of their expression regulation are encouraged.
Does MLMD arise spontaneously in different loci or is it driven by mutations in a candidate’s
genes responsible for genomic imprinting establishment and maintenance? To answer this
question the evidence of MLMD in patients with imprinting disorders should be discussed.
5. Multiple methylation defects in patients with imprinting disorders
The first evidence of multiple epimutations of imprinted genes was obtained in 2005 in the
comparative analysis of methylation status of two genes – ZAC (PLAGL1) and LIT1
(KCNQ1OT1) in eight patients with BWS and 17 patients with TNDM [54]. The idea for this
study was based on the fact that there is partial overlapping of some clinical features in these
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syndromes. This observation may reflect possible interactions between PLAGL1 and P57KIP2
genes. According to the author’s suggestion, an overexpression of PLAGL1 due to the loss of
methylation of inactive maternal allele may lead to the suppression or inhibition of cyclin-
dependent kinases P57KIP2 through the hyperactivation of LIT1 (KCNQ1OT1). It was shown
that all eight BWS patients had normal PLAGL1 methylation, whereas in two patients with
TNDM hypomethylation at LIT1 was detected. The first patient had UPD(6)pat. The second
one had a normal karyotype, but, typically for TNDM, a loss of methylation at PLAGL1 on
maternal chromosome 6. It is interesting that in the latter patient’s situation, clinical signs of
TNDM were supplemented with umbilical hernia and macroglassia that are typical for BWS.
In 2006, Mackay and colleagues reported on a study of two patients with TNDM and IUGR
who had hypomethylation of ZAC and KCNQ1OT1 on maternal chromosomes 6 and 11
respectively [55]. Significantly, both patients did not have the overgrowth which is typical for
BWS in the case of KCNQ1OT1 hypomethylation. However, they had moderate macroglassia,
which is not typical for TNDM, and abdomen wall defects and exomphalos that are frequent
in both syndromes.
Later in 2006, Mackay and colleagues described another 12 patients with TNDM and hypo‐
methylation of ZAC on maternal chromosome 6q24 [56]. In six patients (50%) additional
methylation defects were found in different imprinted genes. It was hypomethylation of
GRB10, PEG1/MEST, KCNQ1OT1, and PEG3 on maternal chromosomes in different combina‐
tions. All patients with multiple methylation defects had higher birth weight and were more
phenotypically diverse than other TNDM patients with different genetic aetiologies, except
for ZAC hypomethylation, presumably reflecting the influence of dysregulation of multiple
imprinted genes. It was proposed the existence of a “maternal hypomethylation syndrome”
(MHS), when a patient with the loss of methylation at one maternally-methylated locus may
also manifest DNA methylation loss at other loci, potentially complicated or even confounded
the clinical presentation [56].
Another specific finding of this study which is also very intriguing, is that the level of mosai‐
cism for the DNA methylation index varied in different investigated tissues (blood, mouth‐
brushes, fibroblasts) and affected different genes. The presence of mosaicism indicates
postzygotyic errors of imprinting maintenance in somatic cells. However, it is more significant
that such errors affected only maternally, but not paternally inherited alleles. This type of
epigenetic mosaicism may explain another interesting fact that all patients with MHS had a
major clinical manifestation of TNDM but no other genomic imprinting disorders that can be
expected from the involvement of different imprinted genes. It is reasonable to assume that
germinal epimutations at ZAC, which in theory must be presented (or at least maintained) in
all somatic cells, should lead to TNDM symptoms, whereas somatic epimutations at other
different genes can partially modify only a clinical manifestation of the “main” hereditary
imprinting syndrome.
Later, MLMD were also reported in other imprinting disorders. However, both maternal and
paternal alleles were affected in comparison with MHS. Hypermethylation and hypomethy‐
lation of imprinted genes were reported also. For example, in some cases of BWS, loss of
methylation at KCNQ1OT1 was accompanied by hypomethylation at PLAGL1, PEG/MEST and
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SNURF-SNRPN [57]. In some patients with SRS, hypomethylation at GRB10 and IGF2/H19 was
observed [58, 59]. Multiple epimutations were observed at H19, PEG3, NESPAS and GNAS
genes in one patient with overlapping clinical symptoms of PWS and BWS [60].
It was mentioned earlier that microarray technologies allow us to obtain comprehensive data
sets about the methylation status of imprinted genes over the whole genome. In a recent study,
65 patients with different genomic imprinting disorders (BWS, SRS, PWS, AS, TNDM and
pseudohypoparathyroidism (PHP-1B)) were investigated by using “GoldenGate Cancer Panel
I” (Illumina) DNA methylation microarray [61]. MLMD were detected in all the diseases except
PWS and AS, which demonstrated methylation defects at SNRPN only. Multiple epimutations
were observed in 33% of BWS patients with KCNQ1OT1 hypomethylation, 75% of TNDM
patients with PLAGL1 hypomethylation, 50% of PHP-1B patients with GNASXL/EX1A
hypomethylation, and in 17% of SRS patients with H19 hypomethylation. MLMD involved an
additional one to 16 imprinted genes in each patient.
Thus, examinations of patients with imprinting disorders indicate that the epigenetic basis of
these diseases may, in some cases, be supplemented by multiple methylation defects in several
other imprinting genes in addition to epimutation at the disease-specific gene, which is
responsible for the pathogenesis of major clinical features of a given syndrome. The incidence
of MLMD in different imprinting disorders varies from 8.9% (SRS) to 56.3% (TNDM) (Table
5). The incidence of methylation defects at different genes varies also. The KCNQ1OT1, H19,
and GNAS/NESPAS genes are the most frequently involved in MLMD. On the other hand,
SNURF-SNRPN imprinting centre is a very rare subject in the study of methylation defects in
BWS and SRS patients, and scarcely noted in the list of MLMD affected genes in patients with
TNDM and MHS.
Is the combination of imprinted genes affected by MLMD in different syndromes and preg‐
nancy losses non-random? Are there any specific features of nucleotide sequences and
mechanisms of expression regulation of imprinted genes with different incidence of methyl‐
ation defects? Does an interaction between imprinted genes that may lead to formation of
specific epigenotype and phenotype exist? Further studies are necessary to obtain answers to
these questions. However, there is some data which indicates the existence of coordination
mechanisms in the regulation of epigenetic status of human imprintome. For example, it was
shown that epigenetic changes in the cases of BiCHM and TNDM affected imprinted genes on
maternal chromosomes only, whereas other non-imprinted genes were not a subject for
epimutations [68, 69]. On the other hand, multiple methylation defects were observed by DNA
methylation array analysis both in imprinted and non-imprinted genes in spontaneous
abortions [50]. It is also possible that MLMD may have a different molecular nature in
comparison with a methylation defect at a single locus. For example, multiple methylation
defects in patients with BWS were observed only in the cases of KCNQ1OT1 hypomethylation,
but not in the ones with H19/IGF2 hypermethylation (Table 5). The possible regulation genetic
mechanisms for epigenetic status of imprinted genes are discussed in the last part of the
chapter.
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PLAGL1
(6q24)
MEST/
PEG1
(7q32)
LIT1 (11p15)
DLK1/
GTL2
(14q32)
SNRPN
(15q11)
IGF2R
(6q25)
GRB10/
MEG1
(7p13)
H19
(11p15)
GNAS/
NESPAS
(20q13)
Ref.
Genes with paternal expression Genes with maternal expression
TNDM 12
PLAGL1
hypometh
50% (6) 12↓ 5↓ 3↓ 0 0 n.a. 3↓ 0 n.a. [56]
TNDM 4
PLAGL1
hypometh
75% (3) 4↓ 0 0 0 0 1↓,1↑ 1↓ 0 0 [61]
Total 16
PLAGL1
hypometh
56.3% (9) 100%
31.4%
(5/16)
18.8%
(3/16)
0 0
12.5%
(2/16)
25.0%
(4/16)
0 0
BWS 40 LIT1 hypometh 25% (10) n.a. 3↓ 40↓ n.a. 1↓ 6↓ n.a. n.a. n.a. [62]
BWS 81 LIT1 hypometh 21% (17) 7↓ 6↓ 81↓ 0 0 6↓ 4↓ 0 10↓ [63]
BWS 68 LIT1 hypometh 23.5% (16) 6↓ 6↓ 68↓ 0 1↓ 10↓ n.a. 1↓ n.a. [64]
BWS 11 LIT1 hypometh 45.5% (5) 0 1↓ 11↓ 2↓ n.a. 2↓ 2↓ 2↓ 2↓ [65]
BWS 24 LIT1 hypometh 25% (6) 2↓ 4↓ 24↓ 0 1↓ n.a. n.a. n.a. n.a. [57]
BWS 43 LIT1 hypometh 33% (14) 3↓ 3↓ 43↓ 0 0 3↓ 3↓ 2↓ 3↑ [61]
Total 267 LIT1 hypometh 25.5% (68)
7.9%
(18/227)
8.6%
(23/267)
100%
0.9%
(2/227)
1.2%
(3/256)
10.9%
(27/243)
6.7%
(9/135)
2.5%
(5/203)
11.9%
(16/135)
BWS 20 H19 hypermeth 0 0 0 0 0 0 0 0 20↑ 0 [63]
SRS 23 H19 hypometh 8.2% (2) 0 0 1↓ 0 n.a. 1↓, 2↑ 1↓ 23↓ 2↓ [66]
SRS 74 H19 hypometh 9.5% (7) 2↓ 3↓ 3↓ 5↓ 1↓ 2↓ n.a. 74↓ n.a. [64]
SRS 65 H19 hypometh 7.7% (5) n.a. 1↓ 3↓ 1↓ n.a. 3↓ 0 65↓ n.a. [67]
SRS 6 H19 hypometh 16.6%(1) 0 1↓ 0 0 0 0 0 6↓ 0 [61]
Total 168 H19 hypometh 8.9% (15)
2.1%
(2/103)
2.5%
(5/168)
4.3%
(7/168)
3.7%
(6/168)
1.4%
(1/80)
4.9%
(8/168)
1.1%
(1/94)
100%
8.7%
(2/29)
PWS/BWS 1
SNRPN
hypometh
– n.a. n.a. 1↓ n.a. 1↓ n.a. n.a. 1↓ 1↓ [60]
PHP-1В 10 GNAS hypometh 50% (5) 0 2↓ 0 0 0 1↓ 0 0 10↓ [61]
Total 476
20.4%
(97/476)
10.3%
(38/370)
7.4%
(35/475)
58.4%
(278/476)
1.8%
(8/435)
1.1%
(4/377)
8.7%
(38/439)
5.2%
(14/269)
47.1%
(194/412)
15.0%
(29/193)
↓ – 75.6% (360/476); ↑ – 0.6% (3/476) ↓ – 52.9% (252/476); ↑ – 4.8% (23/476)
Note: MLMD – multilocus methylation defects (number of patients with MLMD is indicated in parentheses); n.a. – not analysed; ↓ – hypomethylation; ↑ – hyperme‐
thylation.
Table 5. Incidence of methylation defects in patients with imprinting disorders
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6. Genetic control of epigenetic status of imprinted genes
The story begins again with BiCHM. Recurrent cases of this pathology or classical CHM and
PHM in anamnesis, the occurrence of several cases within one pedigree, and the appearance
in consanguineous couples provide evidence for an autosomal recessive mode of inheritance
of BiCHM by maternal lineage. The first candidate’s genes were DNA methyltransferases,
however, the sequencing of it in women with a history of BiCHM did not reveal the presence
of mutations. Subsequent genome-wide association studies and homozigosity mapping
indicated the linkage of BiCHM with chromosomal segment 19q13.42, in which the NLRP7
(NALP7) gene was mapped [70]. In this first study, five mutations of NLRP7 in familial and
recurrent cases of hydatidiform mole were reported. Two mutations, IVS3+1G-A and
IVS7+1G-, were found in introns 3 and 7, respectively. Three single nucleotide changes were
detected in another three families: p.R693W, p.R693P, and p.N913S. All these mutations were
absent in the 348 individuals from the control group.
Homozygous c.295G>T (p.Glu99X) and heterozygous c.1970A>T (p.Asp657Val) mutations
were observed in a woman with four hydatidiform moles [71]. Her sister with two moles and
brother were compound heterozygotes for these mutations. Her father had a homozygous
p.Asp657Val mutation. Her mother had a homozygous p.Glu99X mutation, three successful
pregnancies and a stillbirth in anamnesis. In another studied family, a brother and his three
sisters with recurrent hydatidiform moles (two, three, and five cases in anamnesis, respec‐
tively) were homozygous for p.Arg693Pro mutations, but the brother did not have any
reproductive problems. The authors of this study made a very important conclusion that
mutations of NLRP7 do not affect the foetal development in the case of paternal inheritance,
but lead to recurrent hydatidiform moles when transmitted from the mother.
Several studies combined methylation analysis of imprinted genes and the search for NLRP7
mutations. For example, homozygous c.2248C>G (p.L750V), c.2471+1G>A missense mutations
and heterozygous c.2248C>G (p.Leu750Val), c.2810+2T>G NLRP7 mutations in women with
BiCHM and multiple hypomethylation at the PEG3, SNRPN, KCNQ1OT1, GNAS imprinted
genes were reported [72]. Studying 11 families with BiCHM, Hayward and colleagues
performed methylation analysis of the ZAC, GNAS-NESP55, LIT1/KCNQ1OT1, and SGCE/
PEG10 genes in four families. Hypomethylation of maternal alleles at the ZAC and LIT1 as well
as hypermethylation of maternal alleles at the NESP55, which is unusual for BiCHM, were
observed in all four families. The sequencing of NLRP7 revealed eight not previously described
mutations: p.K116X, p.L398R, p.S673X, p.W778X, c.939_952dup14, c.1456dupG, c.2030delT,
and c.277+1G>C [73]. Moreover, p.L398R was associated with multiple epimutations of
imprinted genes indicating that some mutations in NLRP7 may be connected with different
types of methylation defects, but not restricted by the hypomethylation of maternal alleles
only.
A search for NLRP7 mutations was performed in 40 Tunisian families with sporadic hydati‐
diform moles [74, 75]. Two sisters in one family had a homozygous mutation p.E570X.
Heterozygous mutations were found in 11 patients. There were several new mutations among
them: c.544G>A (p.Val182Met), c.1480G>A (p.Ala494Thr), c.1532A>G (p.Lys511Arg) and c.
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2156C>T (p.Ala719Val). The authors concluded that the presence of some heterozygous
mutations of NLRP7 in woman may be a risk factor not only for BiCHM, but also for a sporadic
mole.
There are current reports on mutations at almost all exons and introns of NLRP7 gene, which
were associated with BiCHM. The product of the gene belongs to CATERPILLER proteins
family. These NLRP proteins are implicated in the activation of proinflammatory caspases
through multiprotein complexes called inflammasomes. This gene may act as a feedback
regulator of caspase-1-dependent interleukin 1-beta secretion, which is pleiotropic cytokine
involved in trophoblast invasion in the uterus during implantation [76].
As mentioned previously, NLRP7 may be a gene with a maternal effect. The products of such
genes are necessary for oocytes to support early embryo development before the activation of
embryo genome. These genes do not have an influence on ovulation and fertilization, but the
absence of their products leads to the termination of early embryo development. This feature
may explain the lack of reproductive problems in NLRP7 mutation’s male carriers. It seems
that another gene from the NRLP family in mice – Nalp5, is a gene with maternal effect also.
Nalp5-/- females had normal ovaries. Their oocytes fertilized normally, but embryos arrested
their development at the 2-cell stage [77].
NLRP7 protein has no DNA-binding motifs in its sequence, which is why it is unclear how it
may be involved in imprinting recording during oogenesis. In this situation, an alternative
hypothesis is attractive. According to this hypothesis, the involvement of NLRP7 in BiCHM
pathogenesis may be related to its participation in inflammation and autoimmune response.
It was found that patients with NLRP7 mutations cannot provide specific responses to different
antigens [78]. As a result, in such women androgenic blastocysts, which are in fact are complete
allografts, can implant and develop without rejection from the maternal side. It is also possible
that androgenic blastocysts arise spontaneously de novo with definite frequency due to errors
of fertilization or through epigenetic mechanisms independently from NRLP7 mutations. In
women without NRLP7 mutations and normal immune systems, such androgenic blastocysts
die or stop in development. It is interesting that mutations in other members of the CATER‐
PILLER family – NLRP1 and NOD2 were also associated with some clinical forms of vitiligo
(MIM #606579) and inflammatory bowel disease (MIM #266600) [78]. There were no reports
on the association of molar pregnancies with these autoimmune diseases, except for one study
[79]. However, the association of Crohn’s disease with recurrent pregnancy loss was noted
repeatedly [80, 81]. It is possible that this association is based on common pathogenic mecha‐
nisms involved in the disturbance of autoimmune response regulation.
Mutations at the NLRP7 gene have not been found in every case of BiCHM and only 48-60%
of patients with recurrent hydatidiform moles indicate a heterogeneous nature of this repro‐
ductive pathology. Indeed, in 2011 a type II of BiCHM was described (MIM #614293), which
is clinically indistinguishable from the classical variant of the biparental complete mole. It was
related to mutations at the KHDC3L (C6orf221) gene in 6q13. The search for mutations in this
gene was performed in 14 pedigrees with BiCHM without NLRP7 mutations. As a result,
homozygous change c.3G>T, deletion c.322_325delGACT and compound heterozygote c.
322_325delGACT were found in three families [82]. This study revealed that KHDC3L is
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mutated in 14% of patients with recurrent a hydatidiform mole who are negative for NLRP7
mutations.
Sequencing of KHDC3L in 97 patients with recurrent moles, reproductive loss and absence of
NLRP7 mutations allows to identify three unrelated patients, each homozygous for one of the
two protein-truncating mutations, a novel 4-bp deletion resulting in a frame shift c.
299_302delTCAA (p.Ile100Argfs*2), and a previously described 4-bp deletion c.322_325del‐
GACT (p.Asp108Ilefs*30), transmitted on a shared haplotype to three patients from different
populations [83]. It was also shown that molar tissues from one of the spontaneous abortions
were diploid and biparental. In this study, immunofluorescence analysis revealed colocaliza‐
tion of KHDC3L and NLRP7 proteins in lymphoblastoid cell lines from normal subjects. Using
cell lines from patients, it was demonstrated that the KHDC3L mutations do not change the
subcellular localization of protein in haematopoietic cells. This finding highlights the similar‐
ities between the two causative genes for recurrent moles, KHDC3L and NLRP7, in their
subcellular localization, the parental contribution to the mole tissues caused by them, and the
presence of several founder mutations and variants in different populations in both of them
indicating positive selection and adaptation.
It is probable that some patients with imprinting disorders and MLMD also have mutations
in two other genes – NLRP2 (NALP2) (19q13.42) and ZFP57 (6p22.1), which may be involved
in imprinting maintenance. The NALP2 is a cytosolic protein of the CATERPILLER’s subfam‐
ily. It is suggested that NALP2 is a component of inflammosomes, like NLRP7. Mutation c.
1479delAG (p.Arg493SerfsX32) at the NLRP2 was found in a family with one healthy child and
two children with BWS [84]. KCNQ1OT1 imprinted centres were hypomethylated in both
affected children, whereas PEG1 hypomethylation was observed in only one of them. Homo‐
zygous mutation at the NLRP2 was detected in the mother and the affected child, whereas the
father, the healthy child and the other diseased child were heterozygotes. The mutation was
absent in the control group. This data is in agreement with the hypothesis that NLRP2 is a
maternal-effect gene, like NLRP7. It is interesting that NLRP2 per se is imprinted. Its monoallelic
expression from the maternal chromosome was detected in decidual tissue, foetal heart and
liver [85]. However, there is a single report, which does not support the maternal effect of
NLRP2. In 2013, a paternally inherited mutation c.2077C>T (p.R693W) was observed in BWS
patient with KCNQ1OT1 hypomethylation [61]. This mutation was absent in individuals from
the control group and may be pathogenic according to the “PolyPhen-2” database. However,
it seems that this example does not cover multiple methylation defects.
In 2008, mutations at the ZNF57 were detected for the first time in seven out of twelve families
with TNDM and multiple hypomethylation of imprinted genes PLAGL1, CRB10, PEG3,
KCNQ1OT1, PEG1/MEST, and NESPAS [86]. Homozygous mutation p.C241X was found in a
brother with hypomethylation at the KCNQ1OT1, NASPAS and PEG1/MEST and his sister
with KCNQ1OT1 and PEG1/MEST hypomethylation. Proband in another family had deletion
c.257_258delAG (p.E86VfsX28). His father was a heterozygote for this deletion. Compound
heterozygous mutation c.683G>A (p.R228H) was detected in two families, including one
patient with hypomethylation of PEG1/MEST and NESPAS. None of the mutations were found
in 200 individuals from the control group.
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Two years later, Mackay and Temple reported about ZFP57 mutations in 10 out of 16 patients
with TNDM and hypomethylation at the PLAGL1, GRB10 and PEG3 genes [87]. It is interesting
that all patients with maternal hypomethylation syndrome, ZFP57 mutations and PLAGL1
hypomethylation also had PEG3 and GRB10 hypomethylation. However, in the absence of
ZFP57 mutations, PEG3 and GRB10 genes were infrequently affected by methylation defects.
This observation indicates that ZFP57 may be involved in imprinting maintenance in somatic
cells in contrast to germinal methylation defects, which are associated with mutations at the
NLRP7.
ZFP57 mutations were also observed in patients with other imprinting disorders, like SRS and
BWS. For example, seven mutations at the ZFP57 were found in 30 patients with SRS and
hypomethylation of imprinting centre H19/IGF2 on chromosome 11 [88]. Other imprinted
genes were not tested in this study. Six nucleotide changes were recognized as known
polymorphisms, whereas one patient had not previously detected homozygous mutation
p.R125Q in the exon 6. This mutation was also found in heterozygous form in two of the 80
(2.5%) healthy individuals.
Twenty-seven BWS patients with KCNQ1OT1 hypomethylation were tested for the presence
of ZFP57 mutations [89]. As a result, three new nucleotide changes were found. Two twin girls
and their father were heterozygous for the c.503C>T (p.Ser168Phe). Two other changes c.
723C>T and c.1026T>C were detected in a diseased child and his father.
ZFP57 mutations were found in a recent study of patients with TNDM, SRS, BWS and
methylation defects [61]. New homozygous deletion c.371delC was identified in a patient with
TNDM and maternal hypomethylation of five imprinted genes, including PLAGL1. Both
parents in this family were heterozygous carriers of deletion, whereas it was absent in the 180
individuals from the control group. Two cases of maternal inheritance of the mutation c.
374G>A (p.R125Q) were observed in a SRS patient with H19/IGF2 hypomethylation and in a
BWS patient with a loss of methylation at the KCNQ1OT1. This mutation was not found in the
control sample. The mother of the SRS patient was a compound heterozygote for p.R125Q and
c.559G>A (p.R187C) mutation.
The protein encoded by ZFP57 is a zinc finger protein containing the Kruppel-associated box
repressor (KRAB) domain, which acts as transcription repressor. It is interesting that this
domain may be involved in the de novo DNA methylation during mouse embryogenesis [90].
It was also shown that Zfp57 mutations in mice may induce multiple methylation defects of
imprinted genes. Partial hypomethylation of maternal and paternal alleles was noted in
progeny with Zfp57-/- genotype in zygote [Li et al., 2008]. The authors of this study suggested
that Zfp57 is a maternal-zygotic effect gene and its product is required for imprinting mainte‐
nance in different genomic loci.
Taking the discussed results together, it is possible to make an unexpected conclusion that
some part of imprinting diseases and reproductive disorders associated with abnormal
imprinting are related to defects in gene (or genes) involved in the establishment and main‐
tenance of epigenetic organization of imprinted loci. In other words, imprinting diseases, or
at least some part of them, that were usually considered epigenetic in nature, have, in fact, a
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single gene basis sometimes modified by parental-of-origin effects. A similar situation is
specific for chromatin diseases (ICF, Rett, Rubinshtein-Taybi, Coffin-Lowry, ATR-X syn‐
dromes), which arise due to mutations in genes involved in the control of chromatin organi‐
zation [8]. From this point of view, the presence of one form of TNDM, a classical imprinting
disorder, in the OMIM catalogue (MIM # 601410) as a result of ZFP57 mutations is not
unexpected.
Considering the high incidence of reproductive losses in humans and the elevated level of
methylation defects at different imprinted loci in spontaneous abortions, the search for
mutations in genes involved in the control of genomic imprinting is a challenge for modern
reproductive epigenetics and medicine. In our preliminary study, 11 first trimester missed
abortions with MLMD of imprinted genes were tested for the presence of NLRP7 mutations
[92]. Nine genetic variants of NLRP7 were found. Seven of them were presented in specific
databases for women with BiCHM and normal reproductive outcomes. Whereas two new
changes, c1405delC and c1444delC, in homozygous form were found in spontaneous abortion
with hypomethylation at the PEG10, KCNQ1, WT1, ZNF215 and hypermethylation at the INS,
PWCR1 and GABRA5 genes.
7. Conclusion
The reviewed data clearly indicates that epigenetic abnormalities are the leading cause of
imprinted gene dysfunction in pregnancy complications and losses. This is not surprising
because of the fact that the rate of epimutations is estimated to be one or two orders higher
than the incidence of classical gene mutations. It is import to also note that epimutation in one
allele is enough to cause the loss of imprinting or the silencing of an imprinted gene due to
one of its main inherent features, namely monoallelic expression.
The application of genome wide technologies of DNA methylation analysis revealed the
phenomenon of multiple methylation defects at imprinting genes both in spontaneous
abortions and in some patients with imprinting disorders. Today we are witnesses of data
accumulation about spectrum and the incidence of this type of methylation abnormalities in
different diseases. However, cautious estimations should be provided because of a lack of
current data about possible benign epipolymorphisms of imprinted genes. However, obtained
results change and supplement existent concepts about pathogenesis of imprinting disorders.
One of the most intriguing findings is that some part of epigenetic imprinting defects has, in
fact, a genetic nature due to mutations in genes, which are responsible for imprinting regula‐
tion. This remark may have obvious significance for the likes of molecular genetic diagnosis
in the light of the application of high-throughput genomic and post-genomic technologies and
for medical genetic counselling. Carriers of mutations in imprinting control genes may have
incorrect or instable epigenomes in their gametes or progeny which will be not compatible
with fertilization, implantation, normal prenatal development or the delivery of a healthy
child. Preimplantation genetic diagnosis for the excluding of embryo transfer with mutations
in such genes may be a successful reproductive choice for such couples.
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